Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Epoetin (Eritropoyetin) Market Growth 2022-2028

  • LP 4838158
  • 104 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Epoetin (Eritropoyetin) will have significant change from previous year. According to our (LP Information) latest study, the global Epoetin (Eritropoyetin) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Epoetin (Eritropoyetin) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Epoetin (Eritropoyetin) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Epoetin (Eritropoyetin) market, reaching US$ million by the year 2028. As for the Europe Epoetin (Eritropoyetin) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Epoetin (Eritropoyetin) players cover Amgen, Epoetin, Abcam, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Epoetin (Eritropoyetin) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Epoetin-alfa

Epoetin-beta

Darbepoetin Alfa

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Anemia (Cancer and HIV Treatment)

Kidney Disorders (ESRD and Dialysis)

Others (Neural Disease and Wound Healing)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Amgen

Epoetin

Abcam

Johnson & Johnson

Hospira Inc

Roche

LG Life Sciences Ltd

Biocon

Intas Pharmaceuticals

Teva Pharmaceutical Industries Ltd

Ranbaxy Laboratories Ltd

Celltrion, Inc

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Epoetin (Eritropoyetin) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Epoetin (Eritropoyetin) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Epoetin (Eritropoyetin) by Country/Region, 2017, 2022 & 2028

2.2 Epoetin (Eritropoyetin) Segment by Type

2.2.1 Epoetin-alfa

2.2.2 Epoetin-beta

2.2.3 Darbepoetin Alfa

2.3 Epoetin (Eritropoyetin) Sales by Type

2.3.1 Global Epoetin (Eritropoyetin) Sales Market Share by Type (2017-2022)

2.3.2 Global Epoetin (Eritropoyetin) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Epoetin (Eritropoyetin) Sale Price by Type (2017-2022)

2.4 Epoetin (Eritropoyetin) Segment by Application

2.4.1 Anemia (Cancer and HIV Treatment)

2.4.2 Kidney Disorders (ESRD and Dialysis)

2.4.3 Others (Neural Disease and Wound Healing)

2.5 Epoetin (Eritropoyetin) Sales by Application

2.5.1 Global Epoetin (Eritropoyetin) Sale Market Share by Application (2017-2022)

2.5.2 Global Epoetin (Eritropoyetin) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Epoetin (Eritropoyetin) Sale Price by Application (2017-2022)

3 Global Epoetin (Eritropoyetin) by Company

3.1 Global Epoetin (Eritropoyetin) Breakdown Data by Company

3.1.1 Global Epoetin (Eritropoyetin) Annual Sales by Company (2020-2022)

3.1.2 Global Epoetin (Eritropoyetin) Sales Market Share by Company (2020-2022)

3.2 Global Epoetin (Eritropoyetin) Annual Revenue by Company (2020-2022)

3.2.1 Global Epoetin (Eritropoyetin) Revenue by Company (2020-2022)

3.2.2 Global Epoetin (Eritropoyetin) Revenue Market Share by Company (2020-2022)

3.3 Global Epoetin (Eritropoyetin) Sale Price by Company

3.4 Key Manufacturers Epoetin (Eritropoyetin) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Epoetin (Eritropoyetin) Product Location Distribution

3.4.2 Players Epoetin (Eritropoyetin) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Epoetin (Eritropoyetin) by Geographic Region

4.1 World Historic Epoetin (Eritropoyetin) Market Size by Geographic Region (2017-2022)

4.1.1 Global Epoetin (Eritropoyetin) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Epoetin (Eritropoyetin) Annual Revenue by Geographic Region

4.2 World Historic Epoetin (Eritropoyetin) Market Size by Country/Region (2017-2022)

4.2.1 Global Epoetin (Eritropoyetin) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Epoetin (Eritropoyetin) Annual Revenue by Country/Region

4.3 Americas Epoetin (Eritropoyetin) Sales Growth

4.4 APAC Epoetin (Eritropoyetin) Sales Growth

4.5 Europe Epoetin (Eritropoyetin) Sales Growth

4.6 Middle East & Africa Epoetin (Eritropoyetin) Sales Growth

5 Americas

5.1 Americas Epoetin (Eritropoyetin) Sales by Country

5.1.1 Americas Epoetin (Eritropoyetin) Sales by Country (2017-2022)

5.1.2 Americas Epoetin (Eritropoyetin) Revenue by Country (2017-2022)

5.2 Americas Epoetin (Eritropoyetin) Sales by Type

5.3 Americas Epoetin (Eritropoyetin) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Epoetin (Eritropoyetin) Sales by Region

6.1.1 APAC Epoetin (Eritropoyetin) Sales by Region (2017-2022)

6.1.2 APAC Epoetin (Eritropoyetin) Revenue by Region (2017-2022)

6.2 APAC Epoetin (Eritropoyetin) Sales by Type

6.3 APAC Epoetin (Eritropoyetin) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Epoetin (Eritropoyetin) by Country

7.1.1 Europe Epoetin (Eritropoyetin) Sales by Country (2017-2022)

7.1.2 Europe Epoetin (Eritropoyetin) Revenue by Country (2017-2022)

7.2 Europe Epoetin (Eritropoyetin) Sales by Type

7.3 Europe Epoetin (Eritropoyetin) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Epoetin (Eritropoyetin) by Country

8.1.1 Middle East & Africa Epoetin (Eritropoyetin) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Epoetin (Eritropoyetin) Revenue by Country (2017-2022)

8.2 Middle East & Africa Epoetin (Eritropoyetin) Sales by Type

8.3 Middle East & Africa Epoetin (Eritropoyetin) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Epoetin (Eritropoyetin)

10.3 Manufacturing Process Analysis of Epoetin (Eritropoyetin)

10.4 Industry Chain Structure of Epoetin (Eritropoyetin)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Epoetin (Eritropoyetin) Distributors

11.3 Epoetin (Eritropoyetin) Customer

12 World Forecast Review for Epoetin (Eritropoyetin) by Geographic Region

12.1 Global Epoetin (Eritropoyetin) Market Size Forecast by Region

12.1.1 Global Epoetin (Eritropoyetin) Forecast by Region (2023-2028)

12.1.2 Global Epoetin (Eritropoyetin) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Epoetin (Eritropoyetin) Forecast by Type

12.7 Global Epoetin (Eritropoyetin) Forecast by Application

13 Key Players Analysis

13.1 Amgen

13.1.1 Amgen Company Information

13.1.2 Amgen Epoetin (Eritropoyetin) Product Offered

13.1.3 Amgen Epoetin (Eritropoyetin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Amgen Main Business Overview

13.1.5 Amgen Latest Developments

13.2 Epoetin

13.2.1 Epoetin Company Information

13.2.2 Epoetin Epoetin (Eritropoyetin) Product Offered

13.2.3 Epoetin Epoetin (Eritropoyetin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Epoetin Main Business Overview

13.2.5 Epoetin Latest Developments

13.3 Abcam

13.3.1 Abcam Company Information

13.3.2 Abcam Epoetin (Eritropoyetin) Product Offered

13.3.3 Abcam Epoetin (Eritropoyetin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Abcam Main Business Overview

13.3.5 Abcam Latest Developments

13.4 Johnson & Johnson

13.4.1 Johnson & Johnson Company Information

13.4.2 Johnson & Johnson Epoetin (Eritropoyetin) Product Offered

13.4.3 Johnson & Johnson Epoetin (Eritropoyetin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Johnson & Johnson Main Business Overview

13.4.5 Johnson & Johnson Latest Developments

13.5 Hospira Inc

13.5.1 Hospira Inc Company Information

13.5.2 Hospira Inc Epoetin (Eritropoyetin) Product Offered

13.5.3 Hospira Inc Epoetin (Eritropoyetin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Hospira Inc Main Business Overview

13.5.5 Hospira Inc Latest Developments

13.6 Roche

13.6.1 Roche Company Information

13.6.2 Roche Epoetin (Eritropoyetin) Product Offered

13.6.3 Roche Epoetin (Eritropoyetin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Roche Main Business Overview

13.6.5 Roche Latest Developments

13.7 LG Life Sciences Ltd

13.7.1 LG Life Sciences Ltd Company Information

13.7.2 LG Life Sciences Ltd Epoetin (Eritropoyetin) Product Offered

13.7.3 LG Life Sciences Ltd Epoetin (Eritropoyetin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 LG Life Sciences Ltd Main Business Overview

13.7.5 LG Life Sciences Ltd Latest Developments

13.8 Biocon

13.8.1 Biocon Company Information

13.8.2 Biocon Epoetin (Eritropoyetin) Product Offered

13.8.3 Biocon Epoetin (Eritropoyetin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Biocon Main Business Overview

13.8.5 Biocon Latest Developments

13.9 Intas Pharmaceuticals

13.9.1 Intas Pharmaceuticals Company Information

13.9.2 Intas Pharmaceuticals Epoetin (Eritropoyetin) Product Offered

13.9.3 Intas Pharmaceuticals Epoetin (Eritropoyetin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Intas Pharmaceuticals Main Business Overview

13.9.5 Intas Pharmaceuticals Latest Developments

13.10 Teva Pharmaceutical Industries Ltd

13.10.1 Teva Pharmaceutical Industries Ltd Company Information

13.10.2 Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Product Offered

13.10.3 Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Teva Pharmaceutical Industries Ltd Main Business Overview

13.10.5 Teva Pharmaceutical Industries Ltd Latest Developments

13.11 Ranbaxy Laboratories Ltd

13.11.1 Ranbaxy Laboratories Ltd Company Information

13.11.2 Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Product Offered

13.11.3 Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Ranbaxy Laboratories Ltd Main Business Overview

13.11.5 Ranbaxy Laboratories Ltd Latest Developments

13.12 Celltrion, Inc

13.12.1 Celltrion, Inc Company Information

13.12.2 Celltrion, Inc Epoetin (Eritropoyetin) Product Offered

13.12.3 Celltrion, Inc Epoetin (Eritropoyetin) Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Celltrion, Inc Main Business Overview

13.12.5 Celltrion, Inc Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Epoetin (Eritropoyetin) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Epoetin (Eritropoyetin) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Epoetin-alfa

Table 4. Major Players of Epoetin-beta

Table 5. Major Players of Darbepoetin Alfa

Table 6. Global Epoetin (Eritropoyetin) Sales by Type (2017-2022) & (Units)

Table 7. Global Epoetin (Eritropoyetin) Sales Market Share by Type (2017-2022)

Table 8. Global Epoetin (Eritropoyetin) Revenue by Type (2017-2022) & ($ million)

Table 9. Global Epoetin (Eritropoyetin) Revenue Market Share by Type (2017-2022)

Table 10. Global Epoetin (Eritropoyetin) Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Epoetin (Eritropoyetin) Sales by Application (2017-2022) & (Units)

Table 12. Global Epoetin (Eritropoyetin) Sales Market Share by Application (2017-2022)

Table 13. Global Epoetin (Eritropoyetin) Revenue by Application (2017-2022)

Table 14. Global Epoetin (Eritropoyetin) Revenue Market Share by Application (2017-2022)

Table 15. Global Epoetin (Eritropoyetin) Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Epoetin (Eritropoyetin) Sales by Company (2020-2022) & (Units)

Table 17. Global Epoetin (Eritropoyetin) Sales Market Share by Company (2020-2022)

Table 18. Global Epoetin (Eritropoyetin) Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Epoetin (Eritropoyetin) Revenue Market Share by Company (2020-2022)

Table 20. Global Epoetin (Eritropoyetin) Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Epoetin (Eritropoyetin) Producing Area Distribution and Sales Area

Table 22. Players Epoetin (Eritropoyetin) Products Offered

Table 23. Epoetin (Eritropoyetin) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Epoetin (Eritropoyetin) Sales by Geographic Region (2017-2022) & (Units)

Table 27. Global Epoetin (Eritropoyetin) Sales Market Share Geographic Region (2017-2022)

Table 28. Global Epoetin (Eritropoyetin) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Epoetin (Eritropoyetin) Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Epoetin (Eritropoyetin) Sales by Country/Region (2017-2022) & (Units)

Table 31. Global Epoetin (Eritropoyetin) Sales Market Share by Country/Region (2017-2022)

Table 32. Global Epoetin (Eritropoyetin) Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Epoetin (Eritropoyetin) Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Epoetin (Eritropoyetin) Sales by Country (2017-2022) & (Units)

Table 35. Americas Epoetin (Eritropoyetin) Sales Market Share by Country (2017-2022)

Table 36. Americas Epoetin (Eritropoyetin) Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Epoetin (Eritropoyetin) Revenue Market Share by Country (2017-2022)

Table 38. Americas Epoetin (Eritropoyetin) Sales by Type (2017-2022) & (Units)

Table 39. Americas Epoetin (Eritropoyetin) Sales Market Share by Type (2017-2022)

Table 40. Americas Epoetin (Eritropoyetin) Sales by Application (2017-2022) & (Units)

Table 41. Americas Epoetin (Eritropoyetin) Sales Market Share by Application (2017-2022)

Table 42. APAC Epoetin (Eritropoyetin) Sales by Region (2017-2022) & (Units)

Table 43. APAC Epoetin (Eritropoyetin) Sales Market Share by Region (2017-2022)

Table 44. APAC Epoetin (Eritropoyetin) Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Epoetin (Eritropoyetin) Revenue Market Share by Region (2017-2022)

Table 46. APAC Epoetin (Eritropoyetin) Sales by Type (2017-2022) & (Units)

Table 47. APAC Epoetin (Eritropoyetin) Sales Market Share by Type (2017-2022)

Table 48. APAC Epoetin (Eritropoyetin) Sales by Application (2017-2022) & (Units)

Table 49. APAC Epoetin (Eritropoyetin) Sales Market Share by Application (2017-2022)

Table 50. Europe Epoetin (Eritropoyetin) Sales by Country (2017-2022) & (Units)

Table 51. Europe Epoetin (Eritropoyetin) Sales Market Share by Country (2017-2022)

Table 52. Europe Epoetin (Eritropoyetin) Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Epoetin (Eritropoyetin) Revenue Market Share by Country (2017-2022)

Table 54. Europe Epoetin (Eritropoyetin) Sales by Type (2017-2022) & (Units)

Table 55. Europe Epoetin (Eritropoyetin) Sales Market Share by Type (2017-2022)

Table 56. Europe Epoetin (Eritropoyetin) Sales by Application (2017-2022) & (Units)

Table 57. Europe Epoetin (Eritropoyetin) Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Epoetin (Eritropoyetin) Sales by Country (2017-2022) & (Units)

Table 59. Middle East & Africa Epoetin (Eritropoyetin) Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Epoetin (Eritropoyetin) Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Epoetin (Eritropoyetin) Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Epoetin (Eritropoyetin) Sales by Type (2017-2022) & (Units)

Table 63. Middle East & Africa Epoetin (Eritropoyetin) Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Epoetin (Eritropoyetin) Sales by Application (2017-2022) & (Units)

Table 65. Middle East & Africa Epoetin (Eritropoyetin) Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Epoetin (Eritropoyetin)

Table 67. Key Market Challenges & Risks of Epoetin (Eritropoyetin)

Table 68. Key Industry Trends of Epoetin (Eritropoyetin)

Table 69. Epoetin (Eritropoyetin) Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Epoetin (Eritropoyetin) Distributors List

Table 72. Epoetin (Eritropoyetin) Customer List

Table 73. Global Epoetin (Eritropoyetin) Sales Forecast by Region (2023-2028) & (Units)

Table 74. Global Epoetin (Eritropoyetin) Sales Market Forecast by Region

Table 75. Global Epoetin (Eritropoyetin) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Epoetin (Eritropoyetin) Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Epoetin (Eritropoyetin) Sales Forecast by Country (2023-2028) & (Units)

Table 78. Americas Epoetin (Eritropoyetin) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Epoetin (Eritropoyetin) Sales Forecast by Region (2023-2028) & (Units)

Table 80. APAC Epoetin (Eritropoyetin) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Epoetin (Eritropoyetin) Sales Forecast by Country (2023-2028) & (Units)

Table 82. Europe Epoetin (Eritropoyetin) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Epoetin (Eritropoyetin) Sales Forecast by Country (2023-2028) & (Units)

Table 84. Middle East & Africa Epoetin (Eritropoyetin) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Epoetin (Eritropoyetin) Sales Forecast by Type (2023-2028) & (Units)

Table 86. Global Epoetin (Eritropoyetin) Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Epoetin (Eritropoyetin) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Epoetin (Eritropoyetin) Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Epoetin (Eritropoyetin) Sales Forecast by Application (2023-2028) & (Units)

Table 90. Global Epoetin (Eritropoyetin) Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Epoetin (Eritropoyetin) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Epoetin (Eritropoyetin) Revenue Market Share Forecast by Application (2023-2028)

Table 93. Amgen Basic Information, Epoetin (Eritropoyetin) Manufacturing Base, Sales Area and Its Competitors

Table 94. Amgen Epoetin (Eritropoyetin) Product Offered

Table 95. Amgen Epoetin (Eritropoyetin) Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Amgen Main Business

Table 97. Amgen Latest Developments

Table 98. Epoetin Basic Information, Epoetin (Eritropoyetin) Manufacturing Base, Sales Area and Its Competitors

Table 99. Epoetin Epoetin (Eritropoyetin) Product Offered

Table 100. Epoetin Epoetin (Eritropoyetin) Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Epoetin Main Business

Table 102. Epoetin Latest Developments

Table 103. Abcam Basic Information, Epoetin (Eritropoyetin) Manufacturing Base, Sales Area and Its Competitors

Table 104. Abcam Epoetin (Eritropoyetin) Product Offered

Table 105. Abcam Epoetin (Eritropoyetin) Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Abcam Main Business

Table 107. Abcam Latest Developments

Table 108. Johnson & Johnson Basic Information, Epoetin (Eritropoyetin) Manufacturing Base, Sales Area and Its Competitors

Table 109. Johnson & Johnson Epoetin (Eritropoyetin) Product Offered

Table 110. Johnson & Johnson Epoetin (Eritropoyetin) Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Johnson & Johnson Main Business

Table 112. Johnson & Johnson Latest Developments

Table 113. Hospira Inc Basic Information, Epoetin (Eritropoyetin) Manufacturing Base, Sales Area and Its Competitors

Table 114. Hospira Inc Epoetin (Eritropoyetin) Product Offered

Table 115. Hospira Inc Epoetin (Eritropoyetin) Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Hospira Inc Main Business

Table 117. Hospira Inc Latest Developments

Table 118. Roche Basic Information, Epoetin (Eritropoyetin) Manufacturing Base, Sales Area and Its Competitors

Table 119. Roche Epoetin (Eritropoyetin) Product Offered

Table 120. Roche Epoetin (Eritropoyetin) Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Roche Main Business

Table 122. Roche Latest Developments

Table 123. LG Life Sciences Ltd Basic Information, Epoetin (Eritropoyetin) Manufacturing Base, Sales Area and Its Competitors

Table 124. LG Life Sciences Ltd Epoetin (Eritropoyetin) Product Offered

Table 125. LG Life Sciences Ltd Epoetin (Eritropoyetin) Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. LG Life Sciences Ltd Main Business

Table 127. LG Life Sciences Ltd Latest Developments

Table 128. Biocon Basic Information, Epoetin (Eritropoyetin) Manufacturing Base, Sales Area and Its Competitors

Table 129. Biocon Epoetin (Eritropoyetin) Product Offered

Table 130. Biocon Epoetin (Eritropoyetin) Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. Biocon Main Business

Table 132. Biocon Latest Developments

Table 133. Intas Pharmaceuticals Basic Information, Epoetin (Eritropoyetin) Manufacturing Base, Sales Area and Its Competitors

Table 134. Intas Pharmaceuticals Epoetin (Eritropoyetin) Product Offered

Table 135. Intas Pharmaceuticals Epoetin (Eritropoyetin) Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 136. Intas Pharmaceuticals Main Business

Table 137. Intas Pharmaceuticals Latest Developments

Table 138. Teva Pharmaceutical Industries Ltd Basic Information, Epoetin (Eritropoyetin) Manufacturing Base, Sales Area and Its Competitors

Table 139. Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Product Offered

Table 140. Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 141. Teva Pharmaceutical Industries Ltd Main Business

Table 142. Teva Pharmaceutical Industries Ltd Latest Developments

Table 143. Ranbaxy Laboratories Ltd Basic Information, Epoetin (Eritropoyetin) Manufacturing Base, Sales Area and Its Competitors

Table 144. Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Product Offered

Table 145. Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 146. Ranbaxy Laboratories Ltd Main Business

Table 147. Ranbaxy Laboratories Ltd Latest Developments

Table 148. Celltrion, Inc Basic Information, Epoetin (Eritropoyetin) Manufacturing Base, Sales Area and Its Competitors

Table 149. Celltrion, Inc Epoetin (Eritropoyetin) Product Offered

Table 150. Celltrion, Inc Epoetin (Eritropoyetin) Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 151. Celltrion, Inc Main Business

Table 152. Celltrion, Inc Latest Developments

List of Figures

Figure 1. Picture of Epoetin (Eritropoyetin)

Figure 2. Epoetin (Eritropoyetin) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Epoetin (Eritropoyetin) Sales Growth Rate 2017-2028 (Units)

Figure 7. Global Epoetin (Eritropoyetin) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Epoetin (Eritropoyetin) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Epoetin-alfa

Figure 10. Product Picture of Epoetin-beta

Figure 11. Product Picture of Darbepoetin Alfa

Figure 12. Global Epoetin (Eritropoyetin) Sales Market Share by Type in 2021

Figure 13. Global Epoetin (Eritropoyetin) Revenue Market Share by Type (2017-2022)

Figure 14. Epoetin (Eritropoyetin) Consumed in Anemia (Cancer and HIV Treatment)

Figure 15. Global Epoetin (Eritropoyetin) Market: Anemia (Cancer and HIV Treatment) (2017-2022) & (Units)

Figure 16. Epoetin (Eritropoyetin) Consumed in Kidney Disorders (ESRD and Dialysis)

Figure 17. Global Epoetin (Eritropoyetin) Market: Kidney Disorders (ESRD and Dialysis) (2017-2022) & (Units)

Figure 18. Epoetin (Eritropoyetin) Consumed in Others (Neural Disease and Wound Healing)

Figure 19. Global Epoetin (Eritropoyetin) Market: Others (Neural Disease and Wound Healing) (2017-2022) & (Units)

Figure 20. Global Epoetin (Eritropoyetin) Sales Market Share by Application (2017-2022)

Figure 21. Global Epoetin (Eritropoyetin) Revenue Market Share by Application in 2021

Figure 22. Epoetin (Eritropoyetin) Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Epoetin (Eritropoyetin) Revenue Market Share by Company in 2021

Figure 24. Global Epoetin (Eritropoyetin) Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Epoetin (Eritropoyetin) Revenue Market Share by Geographic Region in 2021

Figure 26. Global Epoetin (Eritropoyetin) Sales Market Share by Region (2017-2022)

Figure 27. Global Epoetin (Eritropoyetin) Revenue Market Share by Country/Region in 2021

Figure 28. Americas Epoetin (Eritropoyetin) Sales 2017-2022 (Units)

Figure 29. Americas Epoetin (Eritropoyetin) Revenue 2017-2022 ($ Millions)

Figure 30. APAC Epoetin (Eritropoyetin) Sales 2017-2022 (Units)

Figure 31. APAC Epoetin (Eritropoyetin) Revenue 2017-2022 ($ Millions)

Figure 32. Europe Epoetin (Eritropoyetin) Sales 2017-2022 (Units)

Figure 33. Europe Epoetin (Eritropoyetin) Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Epoetin (Eritropoyetin) Sales 2017-2022 (Units)

Figure 35. Middle East & Africa Epoetin (Eritropoyetin) Revenue 2017-2022 ($ Millions)

Figure 36. Americas Epoetin (Eritropoyetin) Sales Market Share by Country in 2021

Figure 37. Americas Epoetin (Eritropoyetin) Revenue Market Share by Country in 2021

Figure 38. United States Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Epoetin (Eritropoyetin) Sales Market Share by Region in 2021

Figure 43. APAC Epoetin (Eritropoyetin) Revenue Market Share by Regions in 2021

Figure 44. China Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Epoetin (Eritropoyetin) Sales Market Share by Country in 2021

Figure 51. Europe Epoetin (Eritropoyetin) Revenue Market Share by Country in 2021

Figure 52. Germany Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Epoetin (Eritropoyetin) Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Epoetin (Eritropoyetin) Revenue Market Share by Country in 2021

Figure 59. Egypt Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Epoetin (Eritropoyetin) Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Epoetin (Eritropoyetin) in 2021

Figure 65. Manufacturing Process Analysis of Epoetin (Eritropoyetin)

Figure 66. Industry Chain Structure of Epoetin (Eritropoyetin)

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390